Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02NSF
|
|||
| Former ID |
DIB004983
|
|||
| Drug Name |
Oxymorphone
|
|||
| Synonyms |
Oxymorphone (abuse-resistant, pain); Oxymorphone (abuse-resistant, pain), Pain Therapeutics/ King Pharmaceuticals; Oxymorphone (abuse-resistant, pain), Pain Therapeutics/Pfizer
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pain [ICD-11: MG30-MG3Z] | Approved | [1] | |
| Therapeutic Class |
Neurology Agents
|
|||
| Company |
Pain Therapeutics Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H19NO4
|
|||
| Canonical SMILES |
CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
|
|||
| InChI |
1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1
|
|||
| InChIKey |
UQCNKQCJZOAFTQ-ISWURRPUSA-N
|
|||
| CAS Number |
CAS 76-41-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
10219, 81989, 841905, 11039374, 14751763, 14898432, 39317908, 46505296, 48416368, 50523562, 57359138, 92714667, 96025010, 103250876, 103916122, 118046192, 126629458, 129404545, 134223676, 134338383, 134971543, 137003774, 139076556, 152101651, 160964525, 162224633, 175267332, 178103672, 179117107, 210279774, 210282097, 223440572, 223822210, 226395721, 252355643
|
|||
| ChEBI ID |
CHEBI:7865
|
|||
| ADReCS Drug ID | BADD_D01648 ; BADD_D01649 | |||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Opioid receptor (OPR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7094). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.